# EDGAR Filing Document

**Accession Number:** 0000039368
**File Stem:** 0001437749-23-001283
**Filing Date:** 2023-1
**Character Count:** 58619
**Document Hash:** 0065f2096ac09239822f14ce51fecfc2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-23-001283.hdr.sgml**: 20230119

**ACCESSION NUMBER**: 0001437749-23-001283

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20230118

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230119

**DATE AS OF CHANGE**: 20230119

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FULLER H B CO
- **CENTRAL INDEX KEY:** 0000039368
- **STANDARD INDUSTRIAL CLASSIFICATION:** ADHESIVES & SEALANTS [2891]
- **IRS NUMBER:** 410268370
- **STATE OF INCORPORATION:** MN
- **FISCAL YEAR END:** 1126

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-09225
- **FILM NUMBER:** 23536069

**BUSINESS ADDRESS:**
- **STREET 1:** 1200 WILLOW LAKE BLVD
- **CITY:** ST PAUL
- **STATE:** MN
- **ZIP:** 55110-5132
- **BUSINESS PHONE:** 6126453401

**MAIL ADDRESS:**
- **STREET 1:** 1200 WILLOW LAKE BLVD
- **CITY:** ST PAUL
- **STATE:** MN
- **ZIP:** 55110-5132

ful20230118_8k.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

------

**FORM **8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

------

Date of Report (Date of earliest event reported): January 18, 2023

**H.B. Fuller Company**

(Exact Name of Company as Specified in Charter)

---

| | | |
|:---|:---|:---|
| Minnesota | 001-09225 | 41-0268370 |
| (State or other jurisdiction of<br> incorporation) | (Commission File Number) | (IRS Employer Identification No.) |

---

---

| | |
|:---|:---|
| 1200 Willow Lake Boulevard, P.O. Box 64683, St. Paul, Minnesota | 55164-0683 |
| (Address of principal executive offices) | (Zip Code) |

---

Company's telephone number, including area code: (651) 236-5900

(Former name or former address, if changed since last report)<br>

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $1.00 | FUL | NYSE |

---

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 DFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 2.02.** | **Results of Operations and Financial Condition.** |

---

On January 18, 2023, H.B. Fuller Company (the "Company") announced its operating results for the fourth quarter and fiscal year ended December 3, 2022. A copy of the press release that discusses this matter is furnished as Exhibit 99.1 to, and incorporated by reference in, this report.

The information in this Item 2.02 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits.** |

---

(d) Exhibits.

---

| | |
|:---|:---|
| 99.1 | [Press Release, dated January 18, 2023, issued by H.B. Fuller Company](ex_465078.htm) |

---

---

| | |
|:---|:---|
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 19, 2023

---

| | |
|:---|:---|
| **H.B. FULLER COMPANY** | **H.B. FULLER COMPANY** |
| By:  | &nbsp;&nbsp;&nbsp; /s/ Timothy J. Keenan |
|  | &nbsp;&nbsp;&nbsp; Timothy J. Keenan |
|  | &nbsp;&nbsp;&nbsp; Senior Vice President, General Counsel<br> and Corporate Secretary |

---

## Exhibit 99.1

---

| | |
|:---|:---|
| ![a01.jpg](a01.jpg)<br> Worldwide Headquarters<br> 1200 Willow Lake Boulevard<br> St. Paul, Minnesota 55110-5101<br>| **Exhibit 99.1**<br>Steven Brazones<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investor Relations Contact<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;651-236-5060 |
| **NEWS** | **January 18, 2023** |

---

**H.B. Fuller Reports Fourth Quarter and Fiscal Year 2022 Results**

ST. PAUL, Minn. – H.B. Fuller Company (NYSE: FUL) today reported financial results for its fourth quarter and fiscal year that ended December 3, 2022.

**Fiscal Year 2022 Noteworthy Items:**

&nbsp;&nbsp;&nbsp;&nbsp;■ Net revenue of $3.75 billion, up 14% versus fiscal year 2021; organic revenue up 17% year-on-year, driven by responsibly strong pricing execution;

&nbsp;&nbsp;&nbsp;&nbsp;■ Net income of $180 million or $3.26 per share (diluted); adjusted EPS of $4.00 per share (diluted), up 15% year-on-year; unfavorable foreign currency exchange reduced adjusted EPS by approximately $0.56, or 16% versus the prior year;

&nbsp;&nbsp;&nbsp;&nbsp;■ Adjusted EBITDA of $530 million, up 14% year-on-year on pricing gains and strong execution, more than overcoming significant year-on-year raw material inflation and unfavorable foreign currency impacts;

&nbsp;&nbsp;&nbsp;&nbsp;■ Cash flow from operations of $257 million, up 20% year-on-year;

&nbsp;&nbsp;&nbsp;&nbsp;■ As a reminder, there was one additional reporting week in fiscal year 2022, which positively impacted net revenue and adjusted EBITDA growth versus 2021 by approximately 2% for the year and 7.5% for the fourth quarter; the definition of organic growth excludes the impact of the extra week.

**Fourth Quarter 2022 Noteworthy Items:**

&nbsp;&nbsp;&nbsp;&nbsp;■ Net revenue of $958 million, up 7% year-on-year; organic revenue increased 6% year-on-year, driven by strong organic growth in both Hygiene, Health, and Consumable and Engineering Adhesives and solid pricing execution in all three GBUs;

&nbsp;&nbsp;&nbsp;&nbsp;■ Net Income was $48 million; adjusted EBITDA of $141 million was up 5% year-on-year and adjusted EBITDA margin was 14.7%;

&nbsp;&nbsp;&nbsp;&nbsp;■ Reported EPS (diluted) was $0.87; adjusted EPS (diluted) was $1.04, down slightly versus the prior year due to raw material inflation, higher interest expense and unfavorable foreign currency exchange impacts; unfavorable foreign currency exchange reduced adjusted EPS in the quarter by approximately $0.22, or 20% versus the prior year;

------

&nbsp;&nbsp;&nbsp;&nbsp;■ Net working capital, as a percentage of annualized net revenue, decreased 100 basis points sequentially from 18.9% in the third quarter to 17.9% in the fourth quarter;

&nbsp;&nbsp;&nbsp;&nbsp;■ Net debt-to-adjusted EBITDA ratio declined sequentially from 3.6X to 3.2X driven by improved cash flow from operations and growth in adjusted EBITDA.

**Fiscal Year 2022 Summary:**

Net revenue for fiscal year 2022 was $3.75 billion, up 14% versus fiscal year 2021. Organic revenue was up 17% year-on-year, with volume up 1% and the rest of the increase driven by higher year-on-year pricing. Unfavorable foreign currency exchange rates reduced net revenue growth by 5.8 percentage points, acquisitions increased net revenue growth by 1.6 percentage points, and the extra week in the fiscal year increased net revenue growth by 2.0 percentage points.

Net income attributable to H.B. Fuller for fiscal 2022 was $180 million, or $3.26 per diluted share. Adjusted net income attributable to H.B. Fuller was $221 million, or $4.00 per diluted share, up 15% compared to $3.47 per diluted share, in fiscal year 2021. Adjusted EBITDA for fiscal year 2022 was $530 million, up 14% versus adjusted EBITDA of $467 million in fiscal year 2021.

**Summary of Fourth Quarter 2022 Results:**

Net revenue for the fourth quarter of fiscal 2022 was $958 million, up 7% versus the fourth quarter of fiscal 2021. Organic revenue was up 6.4% year-on-year, as strong pricing actions increased revenue by 11.4% and volume was down 5.0% due to a slowdown in end market demand, particularly in Construction Adhesives, and softness in China due to more severe COVID-related lockdowns. Unfavorable foreign currency exchange rates reduced net revenue growth by 8.7 percentage points, acquisitions increased net revenue growth by 1.6 percentage points, and the extra week in the fourth quarter increased net revenue growth by 7.5 percentage points.

Gross profit in the fourth quarter of fiscal 2022 was $248 million. Adjusted gross profit in the fourth quarter of fiscal 2022 was $251 million. Adjusted gross profit margin of 26.2% decreased 90 basis points year-on-year. Raw material inflation and lower volumes, particularly in Construction Adhesives, offset higher pricing versus the prior year and resulted in lower gross profit margin.

------

Selling, general and administrative (SG&A) expense was $158 million in the fourth quarter of fiscal 2022 and adjusted SG&A was $153 million. Adjusted SG&A as a percent of net revenue decreased 130 basis points versus the fourth quarter of last year. The decrease in SG&A, as a percentage of net revenue, was driven by organic revenue growth, lower variable compensation and disciplined expense management.

Net income attributable to H.B. Fuller for the fourth quarter of fiscal 2022 was $48 million, or $0.87 per diluted share. Adjusted net income attributable to H.B. Fuller for the fourth quarter of fiscal 2022 was $58 million. Adjusted EPS was $1.04 per diluted share, down slightly year-on-year due to unfavorable foreign currency translation and higher interest rates.

Adjusted EBITDA in the fourth quarter of fiscal 2022 was $141 million, up 5% compared with the fourth quarter of last year. Adjusted EBITDA margin was relatively stable year-on-year. The increase in adjusted EBITDA was driven by strong pricing actions and good expense management, which offset the impact of significantly higher raw material costs and unfavorable foreign currency translation.

"We delivered double-digit growth in organic revenue, adjusted EBITDA, and adjusted EPS in fiscal year 2022, driven by market share gains, appropriately strong pricing actions, and improved execution," said Celeste Mastin, H.B. Fuller president and chief executive officer. "I am proud of our team's resilience and determination in executing our winning strategy in the face of significant headwinds, including continued raw material cost inflation, a strengthening U.S. dollar, and higher interest rates."

"At the same time, we recognize that we did not finish the year as strong as we had expected. During the fourth quarter, we experienced a more pronounced and accelerated slowdown in demand for Construction Adhesives than we anticipated, which was driven by customer inventory de-stocking actions prior to the end of the calendar year. Additionally, we experienced unexpected softness in China due to more dramatic COVID-related lockdowns and on a global basis, greater than expected headwinds from foreign currency translation.

"As we look to the year ahead, we expect global economic conditions to remain slow and we are prepared to control expenses, expand margins by continuing to innovate for our customers and benefiting from scale with our suppliers, and grow cash flow in such an environment. We have managed pricing well in the face of unprecedented raw material inflation and we have the tools and capabilities to drive profit growth and meaningful margin expansion going forward.

------

"We are confident and optimistic in our ability to drive organic growth, expand EBITDA margin, and grow EBITDA at a rate consistent with our long-term financial goal of annual double-digit EBITDA growth. We have many competitive advantages to leverage in the current economic environment. In addition to our ability to collaboratively innovate with customers to serve their needs, we have pricing analytics and discipline, robust product substitution capabilities, and a track record of executing nimbly. I have great confidence in our strategy, and I see tremendous potential for continued strong financial performance."

**Balance Sheet and Cash Flow Items:**

At the end of the fourth quarter of fiscal 2022 net debt was $1,685 million, down $172 million sequentially versus the third quarter. The sequential reduction in net debt, together with growth in adjusted EBITDA, reduced the ratio of net debt-to-adjusted EBITDA from 3.6X to 3.2X sequentially.

Net working capital in the fourth quarter of fiscal 2022 declined $73 million sequentially versus the third quarter. As a percentage of annualized net revenue, net working capital declined 100 basis points sequentially from 18.9% in the third quarter to 17.9%. Cash flow from operations in the fourth quarter was $208 million, up $150 million sequentially versus the third quarter and up $156 million year-on-year, reflecting actions taken to reduce net working capital requirements.

**Fiscal 2023 Outlook:**

&nbsp;&nbsp;&nbsp;&nbsp;■ Adjusted EBITDA for fiscal 2023 is expected to be in the range of $580 million to $610 million, equating to growth of approximately 9% to 15% versus fiscal year 2022;

&nbsp;&nbsp;&nbsp;&nbsp;■ Revenue for 2023 is expected to be flat to down 3% versus 2022; organic revenue growth for fiscal year 2023 is expected to be in the range of 2% to 4%, adjusting for the impact of the extra week in fiscal year 2022;

&nbsp;&nbsp;&nbsp;&nbsp;■ Fiscal year 2023 will be a 52-week year compared to a 53-week year in fiscal year 2022, which will unfavorably impact year-on-year net revenue and adjusted EBITDA growth by approximately 2% in fiscal year 2023;

&nbsp;&nbsp;&nbsp;&nbsp;■ Foreign currency translation is expected to unfavorably impact net revenue growth by between 3% to 4% in fiscal year 2023, with the first half of the year being more heavily impacted given the significant strengthening of the U.S. dollar that occurred in the second half of fiscal year 2022;

&nbsp;&nbsp;&nbsp;&nbsp;■ The core tax rate, excluding the impact of discrete items, is anticipated to be between 27% and 29% in fiscal year 2023

&nbsp;&nbsp;&nbsp;&nbsp;■ Net interest expense for fiscal 2023 is expected to be between $115 million and $125 million, up from fiscal year 2022, reflecting higher interest rates;

&nbsp;&nbsp;&nbsp;&nbsp;■ Adjusted EPS in fiscal year 2023 is expected to be in the range of $4.15 to $4.55, equating to growth of between 4% to 14% year-on-year, despite the significantly stronger U.S. dollar, higher borrowing costs, weakening global economic demand conditions, and one less week in fiscal 2023;

&nbsp;&nbsp;&nbsp;&nbsp;■ Operating cash flow in fiscal year 2023 is expected to be between $300 million and $350 million, being more weighted to the second half of the year, and capital expenditures are expected to be $120 million.

------

**Conference Call:** 

The company will hold a conference call on January 19, 2023, at 9:30 a.m. CT (10:30 a.m. ET) to discuss its results. Interested parties may listen to the conference call on a live webcast. The webcast, along with a supplemental presentation, may be accessed from the company's website at <u>https://investors.hbfuller.com</u>. Participants must register prior to accessing the webcast using this link and should do so at least 10 minutes prior to the start of the call to install and test any necessary software and audio connections. A telephone replay of the conference call will be available from 12:30 p.m. CT on January 19, 2023, through 10:59 p.m. CT on January 26, 2023. To access the telephone replay dial 1-800-770-2030 (toll free) or 1-647-362-9199, and enter Conference ID: 6370505.

**Regulation G**

The information presented in this earnings release regarding consolidated and segment organic revenue growth, operating income, adjusted gross profit, adjusted gross profit margin, adjusted selling, general and administrative expense, adjusted income before income taxes and income from equity investments, adjusted income taxes, adjusted effective tax rate, adjusted net income, adjusted diluted earnings per share and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) does not conform to U.S. generally accepted accounting principles (U.S. GAAP) and should not be construed as an alternative to the reported results determined in accordance with U.S. GAAP. Management has included this non-GAAP information to assist in understanding the operating performance of the company and its operating segments as well as the comparability of results to the results of other companies. The non-GAAP information provided may not be consistent with the methodologies used by other companies. All non-GAAP information is reconciled with reported U.S. GAAP results in the "Regulation G Reconciliation" tables in this press release with the exception of our forward-looking non-GAAP measures contained above in our Fiscal 2023 Outlook, which the company cannot reconcile to forward-looking GAAP results without unreasonable effort.

**About H.B. Fuller**

Since 1887, H.B. Fuller has been a leading global adhesives provider focusing on perfecting adhesives, sealants and other specialty chemical products to improve products and lives. With fiscal 2022 net revenue of $3.75 billion, H.B. Fuller's commitment to innovation and sustainable adhesive solutions brings together people, products and processes that answer and solve some of the world's biggest challenges. Our reliable, responsive service creates lasting, rewarding connections with customers in electronics, disposable hygiene, medical, transportation, aerospace, clean energy, packaging, construction, woodworking, general industries and other consumer businesses. Our promise to our people connects them with opportunities to innovate and thrive. For more information, visit us at <u>https://www.hbfuller.com</u>.

------

**Safe Harbor for Forward-Looking Statements**

Certain statements in this press release may be considered forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases. These statements are subject to various risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including but not limited to the following: the consequences of the COVID-19 outbreak and other pandemics on our operations and financial results; the impact on the supply chain, raw material costs and pricing of our products due to the Russia-Ukraine war; the impact on our margins and product demand due to inflationary pressures; the substantial amount of debt we have incurred to finance our acquisition of Royal, our ability to repay or refinance our debt or to incur additional debt in the future, our need for a significant amount of cash to service and repay the debt and to pay dividends on our common stock, the effect of debt covenants that limit the discretion of management in operating the business or in paying dividends; our ability to pay dividends and to pursue growth opportunities if we continue to pay dividends according to the current dividend policy; our ability to achieve expected synergies, cost savings and operating efficiencies from our restructuring initiatives and operational improvement projects within the expected time frames or at all; our ability to effectively implement Project ONE; uncertain political and economic conditions; fluctuations in product demand; competing products and pricing; our geographic and product mix; availability and price of raw materials; disruptions to our relationships with our major customers and suppliers; failures in our information technology systems; regulatory compliance across our global footprint; trade policies and economic sanctions impacting our markets; changes in tax laws and tariffs; devaluations and other foreign exchange rate fluctuations; the impact of litigation and investigations, including for product liability and environmental matters; impairment charges on our goodwill or long-lived assets; the effect of new accounting pronouncements and accounting charges and credits; and similar matters.

Additional information about these various risks and uncertainties can be found in the "Risk Factors" section of our Form 10-K filings, and any updates to the risk factors in our Form 10-Q and 8-K filings with the SEC, but there may be other risks and uncertainties that we are unable to identify at this time or that we do not currently expect to have a material impact on the business. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

------

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **CONSOLIDATED FINANCIAL INFORMATION** |
| **In thousands, except per share amounts (unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months**<br> **Ended** | | **Three Months** <br> **Ended** | |
|  | **December 3,** <br> **2022** | **Percent of** <br> **Net Revenue** | **November 27,** <br> **2021** | **Percent of** <br> **Net Revenue** |
| Net revenue | $958213 | 100.0% | $897424 | 100.0% |
| Cost of sales | (710092) | (74.1)% | (655965) | (73.1)% |
| Gross profit | 248121 | 25.9% | 241459 | 26.9% |
| Selling, general and administrative expenses | (157872) | (16.5)% | (165789) | (18.5)% |
| Other income, net | 251 | 0.0% | 6954 | 0.8% |
| Interest expense | (30046) | (3.1)% | (18392) | (2.0)% |
| Interest income | 1609 | 0.2% | 1767 | 0.2% |
| Income before income taxes and income from equity method investments | 62063 | 6.5% | 65999 | 7.4% |
| Income taxes | (15163) | (1.6)% | (16671) | (1.9)% |
| Income from equity method investments | 1429 | 0.1% | 1587 | 0.2% |
| Net income including non-controlling interest | 48329 | 5.0% | 50915 | 5.7% |
| Net income attributable to non-controlling interest | (24) | (0.0)% | (31) | (0.0)% |
| Net income attributable to H.B. Fuller | $48305 | 5.0% | $50884 | 5.7% |
| Basic income per common share attributable to H.B. Fuller | $0.90 |  | $0.96 |  |
| Diluted income per common share attributable to H.B. Fuller | $0.87 |  | $0.93 |  |
| Weighted-average common shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Basic | 53824 |  | 53168 |  |
| &nbsp;&nbsp;&nbsp; Diluted | 55472 |  | 54980 |  |
| Dividends declared per common share | $0.190 |  | $0.168 |  |

---

------

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **CONSOLIDATED FINANCIAL INFORMATION** |
| **In thousands, except per share amounts (unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Year Ended** | | **Year Ended** | |
|  | **December 3,** <br> **2022** | **Percent of** <br> **Net Revenue** | **November 27,** <br> **2021** | **Percent of** <br> **Net Revenue** |
| Net revenue | $3749183 | 100.0% | $3278031 | 100.0% |
| Cost of sales | (2785484) | (74.3)% | (2432709) | (74.2)% |
| Gross profit | 963699 | 25.7% | 845322 | 25.8% |
| Selling, general and administrative expenses | (640981) | (17.1)% | (592710) | (18.1)% |
| Other income, net | 12952 | 0.3% | 32855 | 1.0% |
| Interest expense | (91521) | (2.4)% | (78092) | (2.4)% |
| Interest income | 7779 | 0.2% | 9476 | 0.3% |
| Income before income taxes and income from equity method investments | 251928 | 6.7% | 216851 | 6.6% |
| Income taxes | (77186) | (2.1)% | (63033) | (1.9)% |
| Income from equity method investments | 5665 | 0.2% | 7657 | 0.2% |
| Net income including non-controlling interest | 180407 | 4.8% | 161475 | 4.9% |
| Net income attributable to non-controlling interest | (94) | (0.0)% | (82) | (0.0)% |
| Net income attributable to H.B. Fuller | $180313 | 4.8% | $161393 | 4.9% |
| Basic income per common share attributable to H.B. Fuller | $3.37 |  | $3.05 |  |
| Diluted income per common share attributable to H.B. Fuller | $3.26 |  | $2.97 |  |
| Weighted-average common shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Basic | 53580 |  | 52887 |  |
| &nbsp;&nbsp;&nbsp; Diluted | 55269 |  | 54315 |  |
| Dividends declared per common share | $0.738 |  | $0.665 |  |

---

------

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **REGULATION G RECONCILIATION** |
| **In thousands, except per share amounts (unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
|  | **December 3,** | **November 27,** | **December 3,** | **November 27,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Net income attributable to H.B. Fuller | $48305 | $50884 | $180313 | $161393 |
| Adjustments: |  |  |  |  |
| Acquisition project costs <sup>1</sup> | 1822 | 3344 | 10830 | 5622 |
| Organizational realignment <sup>2</sup> | 1471 | 3670 | 6386 | 12699 |
| Royal restructuring and integration <sup>3</sup> | 1467 | 658 | 2474 | 4195 |
| Project One | 2326 | 2958 | 9885 | 9426 |
| Other <sup>4</sup> | 4524 | 3554 | 12791 | (146) |
| Discrete tax items <sup>5</sup> | 1610 | (796) | 9308 | 4272 |
| Income tax effect on adjustments <sup>6</sup> | (3911) | (4511) | (10699) | (8872) |
| Adjusted net income attributable to H.B. Fuller <sup>7</sup> | 57614 | 59761 | 221288 | 188589 |
| Add: |  |  |  |  |
| Interest expense | 30046 | 18406 | 91547 | 78175 |
| Interest income | (1609) | (1767) | (7790) | (9476) |
| Income taxes | 17464 | 21978 | 78576 | 67632 |
| Depreciation and Amortization expense <sup>8</sup> | 37469 | 35407 | 146394 | 142003 |
| Adjusted EBITDA <sup>7</sup> | 140984 | 133785 | 530015 | 466923 |
| Diluted Shares | 55472 | 54980 | 55269 | 54315 |
| Adjusted diluted income per common share attributable to H.B. Fuller <sup>7</sup> | $1.04 | $1.09 | $4.00 | $3.47 |
| Net revenue | $958213 | $897424 | $3749183 | $3278031 |
| Adjusted EBITDA margin <sup>7</sup> | 14.7% | 14.9% | 14.1% | 14.2% |

---

---

| |
|:---|
| <sup>1</sup> Acquisition project costs include costs related to integrating and accounting for acquisitions. |
| <sup>2</sup> Organizational realignment includes costs incurred as a direct result of the organizational realignment program, including compensation for employees supporting the program, consulting expense and operational inefficiencies related to the closure of production facilities and consolidation of business activities. |
| <sup>3</sup> Royal restructuring and integration program includes costs incurred as a direct result of the Royal restructuring and integration program including compensation for employees supporting the program, consulting expense and operational inefficiencies related to the closure of production facilities and consolidation of business activities. |
| <sup>4</sup> Other expenses, for the fiscal year ended December 3 2022, include a $3.3 million non-cash charge related to the wind down and settlement of the Company's Canadian defined benefit pension plan, $1.3 million of hedging costs related to the Russian ruble devaluation driven by the war in Ukraine, $1.2 million of transactional tax expense associated with an audit settlement, other expenses for COVID-19 testing, vaccinations and exceptional medical claims, and non-cash gains and losses related to legal entity consolidations. |
| <sup>5</sup> Discrete tax items are related to revaluation of cross-currency swap agreements due to depreciation of the Euro versus the U.S. Dollar and various foreign tax matters, offset by the tax effect of legal entity mergers. |
| <sup>6</sup> Represents the difference between income taxes on net income before income taxes and income from equity method investments reported in accordance with U.S. GAAP and adjusted net income before income taxes and income from equity method investments. |
| <sup>7</sup> Adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller, adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures. Adjusted net income attributable to H.B. Fuller is defined as net income before the specific adjustments shown above. Adjusted diluted income per common share is defined as adjusted net income attributable to H.B. Fuller divided by the number of diluted common shares. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation, amortization and the specific adjustments shown above. Adjusted EBITDA margin is defined as adjusted EBITDA divided by net revenue. The table above provides a reconciliation of adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller, adjusted EBITDA and adjusted EBITDA margin to net income attributable to H.B. Fuller, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP. |
| <sup>8</sup> Depreciation and amortization expense added back for EBITDA is adjusted for amounts already included in Adjusted net income attributable to H.B. Fuller totaling ($123) and ($145) for the three months ended December 3, 2022 and November 27, 2021, respectively and ($582) and ($1171) for the fiscal years ended December 3, 2022 and November 27, 2021, respectively. |

---

------

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **SEGMENT FINANCIAL INFORMATION** |
| **In thousands (unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
|  | **December 3,** | **November 27,** | **December 3,** | **November 27,** |
|  | **2022** | **2021** | **2022** | **2021** |
| **Net Revenue:** |  |  |  |  |
| Hygiene, Health and Consumable Adhesives | $443528 | $402834 | $1695934 | $1472756 |
| Engineering Adhesives | 395053 | 371419 | 1532639 | 1371756 |
| Construction Adhesives | 119632 | 123171 | 520610 | 433519 |
| Corporate unallocated |  |  |  |  |
| Total H.B. Fuller | $958213 | $897424 | $3749183 | $3278031 |
| **Segment Operating Income:** |  |  |  |  |
| Hygiene, Health and Consumable Adhesives | $42836 | $39874 | $165786 | $138366 |
| Engineering Adhesives | 53607 | 39333 | 168873 | 135913 |
| Construction Adhesives | 957 | 9174 | 22989 | 14148 |
| Corporate unallocated | (7151) | (12711) | (34930) | (35815) |
| Total H.B. Fuller | $90249 | $75670 | $322718 | $252612 |
| **Adjusted EBITDA <sup>7</sup>** |  |  |  |  |
| Hygiene, Health and Consumable Adhesives | $57684 | $54808 | $223988 | $197479 |
| Engineering Adhesives | 70487 | 57097 | 235948 | 207131 |
| Construction Adhesives | 14571 | 20105 | 74187 | 57890 |
| Corporate unallocated | (1758) | 1775 | (4108) | 4423 |
| Total H.B. Fuller | $140984 | $133785 | $530015 | $466923 |
| **Adjusted EBITDA Margin <sup>7</sup>** |  |  |  |  |
| Hygiene, Health and Consumable Adhesives | 13.0% | 13.6% | 13.2% | 13.4% |
| Engineering Adhesives | 17.8% | 15.4% | 15.4% | 15.1% |
| Construction Adhesives | 12.2% | 16.3% | 14.3% | 13.4% |
| Corporate unallocated | NMP | NMP | NMP | NMP |
| Total H.B. Fuller | 14.7% | 14.9% | 14.1% | 14.2% |
| NMP = non-meaningful percentage |  |  |  |  |

---

------

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **REGULATION G RECONCILIATION** |
| **In thousands, except per share amounts (unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
|  | **December 3,** | **November 27,** | **December 3,** | **November 27,** |
| | **2022** | **2021** | **2022** | **2021** |
| Income before income taxes and income from equity method investments | $62063 | $65999 | $251928 | $216851 |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Acquisition project costs <sup>1</sup> | 1822 | 3344 | 10830 | 5622 |
| &nbsp;&nbsp;&nbsp; Organizational realignment <sup>2</sup> | 1471 | 3670 | 6386 | 12699 |
| &nbsp;&nbsp;&nbsp; Royal restructuring and integration <sup>3</sup> | 1467 | 658 | 2474 | 4195 |
| &nbsp;&nbsp;&nbsp; Project One | 2326 | 2958 | 9885 | 9426 |
| &nbsp;&nbsp;&nbsp; Other <sup>4</sup> | 4524 | 3554 | 12791 | (146) |
| Adjusted income before income taxes and income from equity method investments <sup>9</sup> | $73673 | $80183 | $294294 | $248647 |

---

<sup>9</sup> Adjusted income before income taxes and income from equity investments is a non-GAAP financial measure. Adjusted income before income taxes and income from equity investments is defined as income before income taxes and income from equity investments before the specific adjustments shown above. The table above provides a reconciliation of adjusted income before income taxes and income from equity investments to income before income taxes and income from equity investments, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.<br>

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **REGULATION G RECONCILIATION** |
| **In thousands, except per share amounts (unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
|  | **December 3,** | **November 27,** | **December 3,** | **November 27,** |
| | **2022** | **2021** | **2022** | **2021** |
| Income Taxes | $(15163) | $(16671) | $(77186) | $(63033) |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Acquisition project costs <sup>1</sup> | (613) | (1064) | (2767) | (1559) |
| &nbsp;&nbsp;&nbsp; Organizational realignment <sup>2</sup> | (495) | (1167) | (1635) | (3372) |
| &nbsp;&nbsp;&nbsp; Royal restructuring and integration <sup>3</sup> | (494) | (209) | (707) | (1055) |
| &nbsp;&nbsp;&nbsp; Project One | (783) | (940) | (2067) | (2492) |
| &nbsp;&nbsp;&nbsp; Other <sup>4</sup> | 84 | (1927) | 5786 | 3879 |
| Adjusted income taxes <sup>10</sup> | $(17464) | $(21978) | $(78576) | $(67632) |
| Adjusted income before income taxes and income from equity method investments | $73673 | $80183 | $294294 | $248647 |
| Adjusted effective income tax rate <sup>10</sup> | 23.7% | 27.4% | 26.7% | 27.2% |

---

<sup>10</sup> Adjusted income taxes and adjusted effective income tax rate are non-GAAP financial measures. Adjusted income taxes is defined as income taxes before the specific adjustments shown above. Adjusted effective income tax rate is defined as income taxes divided by adjusted income before income taxes and income from equity method investments. The table above provides a reconciliation of adjusted income taxes and adjusted effective income tax rate to income taxes, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.<br>

------

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **REGULATION G RECONCILIATION** |
| **In thousands (unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
|  | **December 3,** | **November 27,** | **December 3,** | **November 27,** |
| | **2022** | **2021** | **2022** | **2021** |
| Net revenue | $958213 | $897424 | $3749183 | $3278031 |
| Gross profit | $248121 | $241459 | $963699 | $845322 |
| Gross profit margin | 25.9% | 26.9% | 25.7% | 25.8% |
| Adjustments: |  |  |  |  |
| Acquisition project costs <sup>1</sup> | 738 | 156 | 1058 | 219 |
| &nbsp;&nbsp;&nbsp; Organizational realignment <sup>2</sup> | 1211 | 1585 | 3207 | 3851 |
| &nbsp;&nbsp;&nbsp; Royal restructuring and integration <sup>3</sup> | 329 | 138 | 706 | 2100 |
| &nbsp;&nbsp;&nbsp; Project ONE |  |  | 6 | (22) |
| &nbsp;&nbsp;&nbsp; Other <sup>4</sup> | 472 | 204 | 1830 | 1839 |
| Adjusted gross profit <sup>11</sup> | $250871 | $243542 | $970506 | $853309 |
| Adjusted gross profit margin <sup>11</sup> | 26.2% | 27.1% | 25.9% | 26.0% |

---

<sup>11</sup> Adjusted gross profit and adjusted gross profit margin are non-GAAP financial measures. Adjusted gross profit and adjusted gross profit margin is defined as gross profit and gross profit margin excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted gross profit and gross profit margin to gross profit and gross profit margin, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.<br>

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **REGULATION G RECONCILIATION** |
| **In thousands (unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
|  | **December 3,** | **November 27,** | **December 3,** | **November 27,** |
| | **2022** | **2021** | **2022** | **2021** |
| Selling, general and administrative expenses | $(157872) | $(165789) | $(640981) | $(592710) |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Acquisition project costs <sup>1</sup> | 1084 | 3189 | 9772 | 5402 |
| &nbsp;&nbsp;&nbsp; Organizational realignment <sup>2</sup> | 260 | 1420 | 4393 | 8239 |
| &nbsp;&nbsp;&nbsp; Royal restructuring and integration <sup>3</sup> | 1138 | 533 | 1794 | 2177 |
| &nbsp;&nbsp;&nbsp; Project ONE | 2326 | 2957 | 9879 | 9449 |
| &nbsp;&nbsp;&nbsp; Other <sup>4</sup> | (408) | 2529 | 2284 | 2561 |
| Adjusted selling, general and administrative expenses <sup>12</sup> | $(153472) | $(155161) | $(612859) | $(564882) |

---

<sup>12</sup> Adjusted selling, general and administrative expenses is a non-GAAP financial measure. Adjusted selling, general and administrative expenses is defined as selling, general and administrative expenses excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted selling, general and administrative expenses to selling, general and administrative expenses, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.<br>

------

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **REGULATION G RECONCILIATION** |
| **In thousands (unaudited)** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| <br>**Three Months Ended**<br>**December 3, 2022** | **Hygiene, Health**<br>**and Consumable**<br>**Adhesives** | <br>**Engineering**<br>**Adhesives** | <br>**Construction**<br>**Adhesives** | <br>**Total** | <br>**Corporate**<br>**Unallocated** | <br>**H.B. Fuller**<br>**Consolidated** |
| Net income attributable to H.B. Fuller | $45913 | $55900 | $3460 | $105273 | $(56968) | $48305 |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Acquisition project costs <sup>1</sup> |  |  |  |  | 1822 | 1822 |
| &nbsp;&nbsp;&nbsp; Organizational realignment <sup>2</sup> |  |  |  |  | 1471 | 1471 |
| &nbsp;&nbsp;&nbsp; Royal restructuring and integration <sup>3</sup> |  |  |  |  | 1467 | 1467 |
| &nbsp;&nbsp;&nbsp; Project One |  |  |  |  | 2326 | 2326 |
| &nbsp;&nbsp;&nbsp; Other <sup>4</sup> |  |  |  |  | 4524 | 4524 |
| &nbsp;&nbsp;&nbsp; Discrete tax items <sup>5</sup> |  |  |  |  | 1610 | 1610 |
| &nbsp;&nbsp;&nbsp; Income tax effect on adjustments <sup>6</sup> |  |  |  |  | (3911) | (3911) |
| Adjusted net income attributable to H.B. Fuller <sup>7</sup> | 45913 | 55900 | 3460 | 105273 | (47659) | 57614 |
| Add: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Interest expense |  |  |  |  | 30046 | 30046 |
| &nbsp;&nbsp;&nbsp; Interest income |  |  |  |  | (1609) | (1609) |
| &nbsp;&nbsp;&nbsp; Income taxes |  |  |  |  | 17464 | 17464 |
| &nbsp;&nbsp;&nbsp; Depreciation and amortization expense <sup>8</sup> | 11771 | 14587 | 11111 | 37469 |  | 37469 |
| Adjusted EBITDA <sup>7</sup> | $57684 | $70487 | $14571 | $142742 | $(1758) | $140984 |
| Net revenue | $443528 | $395053 | $119632 | $958213 |  | $958213 |
| Adjusted EBITDA margin <sup>7</sup> | 13.0% | 17.8% | 12.2% | 14.9% | NMP | 14.7% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| <br>**Year Ended**<br>**December 3, 2022** | **Hygiene, Health**<br>**and Consumable**<br>**Adhesives** | <br>**Engineering**<br>**Adhesives** | <br>**Construction**<br>**Adhesives** | <br>**Total** | <br>**Corporate**<br>**Unallocated** | <br>**H.B. Fuller**<br>**Consolidated** |
| Net income attributable to H.B. Fuller | $177614 | $177641 | $32474 | $387729 | $(207416) | $180313 |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Acquisition project costs <sup>1</sup> |  |  |  |  | 10830 | 10830 |
| &nbsp;&nbsp;&nbsp; Organizational realignment <sup>2</sup> |  |  |  |  | 6386 | 6386 |
| &nbsp;&nbsp;&nbsp; Royal restructuring and integration <sup>3</sup> |  |  |  |  | 2474 | 2474 |
| &nbsp;&nbsp;&nbsp; Project One |  |  |  |  | 9885 | 9885 |
| &nbsp;&nbsp;&nbsp; Other <sup>4</sup> |  |  |  |  | 12791 | 12791 |
| &nbsp;&nbsp;&nbsp; Discrete tax items <sup>5</sup> |  |  |  |  | 9308 | 9308 |
| &nbsp;&nbsp;&nbsp; Income tax effect on adjustments <sup>6</sup> |  |  |  |  | (10699) | (10699) |
| Adjusted net income attributable to H.B. Fuller <sup>7</sup> | 177614 | 177641 | 32474 | 387729 | (166441) | 221288 |
| Add: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Interest expense |  |  |  |  | 91547 | 91547 |
| &nbsp;&nbsp;&nbsp; Interest income |  |  |  |  | (7790) | (7790) |
| &nbsp;&nbsp;&nbsp; Income taxes |  |  |  |  | 78576 | 78576 |
| &nbsp;&nbsp;&nbsp; Depreciation and amortization expense <sup>8</sup> | 46374 | 58307 | 41713 | 146394 |  | 146394 |
| Adjusted EBITDA <sup>7</sup> | $223988 | $235948 | $74187 | $534123 | $(4108) | $530015 |
| Net revenue | 1695934 | 1532639 | 520610 | $3749183 |  | 3749183 |
| Adjusted EBITDA margin <sup>7</sup> | 13.2% | 15.4% | 14.3% | 14.2% | NMP | 14.1% |

---

---

| |
|:---|
| Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to H.B. Fuller for each segment, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.  |
| NMP = Non-meaningful percentage |

---

------

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **REGULATION G RECONCILIATION** |
| **In thousands (unaudited)** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| <br>**Three Months Ended**<br>**November 27, 2021** | **Hygiene, Health**<br>**and Consumable**<br>**Adhesives** | <br>**Engineering**<br>**Adhesives** | <br>**Construction**<br>**Adhesives** | <br>**Total** | <br>**Corporate**<br>**Unallocated** | <br>**H.B. Fuller**<br>**Consolidated** |
| Net income attributable to H.B. Fuller | $43269 | $41950 | $11384 | $96603 | $(45719) | $50884 |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Acquisition project costs <sup>1</sup> |  |  |  |  | 3344 | 3344 |
| &nbsp;&nbsp;&nbsp; Organizational realignment <sup>2</sup> |  |  |  |  | 3670 | 3670 |
| &nbsp;&nbsp;&nbsp; Royal restructuring and integration <sup>3</sup> |  |  |  |  | 658 | 658 |
| &nbsp;&nbsp;&nbsp; Project One |  |  |  |  | 2958 | 2958 |
| &nbsp;&nbsp;&nbsp; Other <sup>4</sup> |  |  |  |  | 3554 | 3554 |
| &nbsp;&nbsp;&nbsp; Discrete tax items <sup>5</sup> |  |  |  |  | (796) | (796) |
| &nbsp;&nbsp;&nbsp; Income tax effect on adjustments <sup>6</sup> |  |  |  |  | (4511) | (4511) |
| Adjusted net income attributable to H.B. Fuller <sup>7</sup> | 43269 | 41950 | 11384 | 96603 | (36842) | 59761 |
| Add: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Interest expense |  |  |  |  | 18406 | 18406 |
| &nbsp;&nbsp;&nbsp; Interest income |  |  |  |  | (1767) | (1767) |
| &nbsp;&nbsp;&nbsp; Income taxes |  |  |  |  | 21978 | 21978 |
| &nbsp;&nbsp;&nbsp; Depreciation and amortization expense <sup>8</sup> | 11539 | 15147 | 8721 | 35407 |  | 35407 |
| Adjusted EBITDA <sup>7</sup> | $54808 | $57097 | $20105 | $132010 | $1775 | $133785 |
| Net revenue | $402834 | $371419 | $123171 | $897424 |  | $897424 |
| Adjusted EBITDA margin <sup>7</sup> | 13.6% | 15.4% | 16.3% | 14.7% | NMP | 14.9% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| <br>**Year Ended**<br>**November 27, 2021** | **Hygiene, Health**<br>**and Consumable**<br>**Adhesives** | <br>**Engineering**<br>**Adhesives** | <br>**Construction**<br>**Adhesives** | <br>**Total** | <br>**Corporate**<br>**Unallocated** | <br>**H.B. Fuller**<br>**Consolidated** |
| Net income attributable to H.B. Fuller | $151560 | $146050 | $22887 | $320497 | $(159104) | $161393 |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Acquisition project costs <sup>1</sup> |  |  |  |  | 5622 | 5622 |
| &nbsp;&nbsp;&nbsp; Organizational realignment <sup>2</sup> |  |  |  |  | 12699 | 12699 |
| &nbsp;&nbsp;&nbsp; Royal restructuring and integration <sup>3</sup> |  |  |  |  | 4195 | 4195 |
| &nbsp;&nbsp;&nbsp; Project One |  |  |  |  | 9426 | 9426 |
| &nbsp;&nbsp;&nbsp; Other <sup>4</sup> |  |  |  |  | (146) | (146) |
| &nbsp;&nbsp;&nbsp; Discrete tax items <sup>5</sup> |  |  |  |  | 4272 | 4272 |
| &nbsp;&nbsp;&nbsp; Income tax effect on adjustments <sup>6</sup> |  |  |  |  | (8872) | (8872) |
| Adjusted net income attributable to H.B. Fuller <sup>7</sup> | 151560 | 146050 | 22887 | 320497 | (131908) | 188589 |
| Add: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Interest expense |  |  |  |  | 78175 | 78175 |
| &nbsp;&nbsp;&nbsp; Interest income |  |  |  |  | (9476) | (9476) |
| &nbsp;&nbsp;&nbsp; Income taxes |  |  |  |  | 67632 | 67632 |
| &nbsp;&nbsp;&nbsp; Depreciation and amortization expense <sup>8</sup> | 45919 | 61081 | 35003 | 142003 |  | 142003 |
| Adjusted EBITDA <sup>7</sup> | $197479 | $207131 | $57890 | $462500 | $4423 | $466923 |
| Net revenue | $1472756 | $1371756 | $433519 | $3278031 |  | $3278031 |
| Adjusted EBITDA margin <sup>7</sup> | 13.4% | 15.1% | 13.4% | 14.1% | NMP | 14.2% |

---

---

| |
|:---|
| Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to H.B. Fuller for each segment, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.  |
| NMP = Non-meaningful percentage |

---

------

---

| |
|:---|
| **H.B. FULLER COMPANY AND SUBSIDIARIES** |
| **SEGMENT FINANCIAL INFORMATION** |
| **NET REVENUE GROWTH (DECLINE)** |
| **(unaudited)** |

---

---

| | | |
|:---|:---|:---|
| **Net revenue growth versus 2021** | **Three** <br> **Months** <br> **Ended** | **Year Ended** |
|  | **December 3,** <br> **2022** | **December 3,** <br> **2022** |
| Price | 11.4% | 15.4% |
| Volume | (5.0)% | 1.2% |
| &nbsp;&nbsp;&nbsp; Organic Growth <sup>13</sup> | 6.4% | 16.6% |
| Extra Week (53 week year) | 7.5% | 2.0% |
| M&A | 1.6% | 1.6% |
| Constant Currency | 15.5% | 20.2% |
| F/X | (8.7)% | (5.8)% |
| Total H.B. Fuller Net Revenue Growth | 6.8% | 14.4% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Net revenue growth versus 2021** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
|  | **December 3, 2022** | **December 3, 2022** | **December 3, 2022** | **December 3, 2022** | **December 3, 2022** | **December 3, 2022** |
|  |  |  |  |  | **Extra** <br> **Week** |  |
|  | **Net**<br> **Revenue** | **F/X** | **Constant** <br> **Currency** | **M&A** | **(53 week** <br> **year)** | **Organic**<br> **Growth <sup>13</sup>** |
| Hygiene, Health and Consumable Adhesives | 10.1% | (10.0)% | 20.1% | 0.0% | 7.7% | 12.4% |
| Engineering Adhesives | 6.4% | (9.6)% | 16.0% | 0.0% | 7.5% | 8.5% |
| Construction Adhesives | (2.9)% | (1.8)% | (1.1)% | 11.9% | 6.6% | (19.6)% |
| Total H.B. Fuller | 6.8% | (8.7)% | 15.5% | 1.6% | 7.5% | 6.4% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Net revenue growth versus 2021** | **Year Ended** | **Year Ended** | **Year Ended** | **Year Ended** | **Year Ended** | **Year Ended** |
|  | **December 3, 2022** | **December 3, 2022** | **December 3, 2022** | **December 3, 2022** | **December 3, 2022** | **December 3, 2022** |
|  |  |  |  |  | **Extra** <br> **Week** |  |
|  | **Net**<br> **Revenue** | **F/X** | **Constant**<br> **Currency** | **M&A** | **(53 week** <br> **year)** | **Organic** <br> **Growth <sup>13</sup>** |
| Hygiene, Health and Consumable Adhesives | 15.2% | (6.9)% | 22.1% | 0.0% | 2.1% | 20.0% |
| Engineering Adhesives | 11.7% | (6.2)% | 17.9% | 0.0% | 2.0% | 15.9% |
| Construction Adhesives | 20.1% | (1.2)% | 21.3% | 12.4% | 1.9% | 7.0% |
| Total H.B. Fuller | 14.4% | (5.8)% | 20.2% | 1.6% | 2.0% | 16.6% |

---

<sup>13</sup> We use the term "organic revenue" to refer to net revenue, excluding the effect of foreign currency changes and acquisitions and divestitures. Organic growth reflects adjustments for the impact of period-over-period changes in foreign currency exchange rates on revenues, the revenues associated with acquisitions and divestitures and the revenues associated with an extra week in 2022 as it was a 53 week year.

------

---

| |
|:---|
| **CONSOLIDATED BALANCE SHEETS** |
| **H.B. Fuller Company and Subsidiaries** |
| (In thousands, except share and per share amounts) |

---

---

| | | |
|:---|:---|:---|
|  | **December 3,** | **November 27,** |
|  | **2022** | **2021** |
| **Assets** |  |  |
| **Current assets:** |  |  |
| &nbsp;&nbsp;&nbsp; Cash and cash equivalents | $**79910** | $61786 |
| &nbsp;&nbsp;&nbsp; Trade receivables, net | **607365** | 614645 |
| &nbsp;&nbsp;&nbsp; Inventories | **491781** | 448404 |
| &nbsp;&nbsp;&nbsp; Other current assets | **120319** | 96335 |
| **Total current assets** | **1299375** | 1221170 |
| &nbsp;&nbsp;&nbsp; Property, plant and equipment, net | **733667** | 695367 |
| &nbsp;&nbsp;&nbsp; Goodwill | **1392627** | 1298845 |
| &nbsp;&nbsp;&nbsp; Other intangibles, net | **702092** | 687075 |
| &nbsp;&nbsp;&nbsp; Other assets | **335868** | 372073 |
| **Total assets** | $**4463629** | $4274530 |
| **Liabilities, non-controlling interest and total equity** |  |  |
| **Current liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp; Notes payable | $**28860** | $24983 |
| Current maturities of long-term debt |  |  |
| &nbsp;&nbsp;&nbsp; Trade payables | **460669** | 500321 |
| &nbsp;&nbsp;&nbsp; Accrued compensation | **108328** | 109542 |
| &nbsp;&nbsp;&nbsp; Income taxes payable | **18530** | 15943 |
| &nbsp;&nbsp;&nbsp; Other accrued expenses | **89345** | 86061 |
| **Total current liabilities** | **705732** | 736850 |
| &nbsp;&nbsp;&nbsp; Long-term debt, net of current maturities | **1736256** | 1591479 |
| &nbsp;&nbsp;&nbsp; Accrued pension liabilities | **52561** | 71651 |
| &nbsp;&nbsp;&nbsp; Other liabilities | **358286** | 277190 |
| **Total liabilities** | **2852835** | 2677170 |
| Commitments and contingencies (Note 14) |  |  |
| **Equity:** |  |  |
| H.B. Fuller stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp; Preferred stock (no shares outstanding) Shares authorized – 10,045,900 | **-** |  |
| &nbsp;&nbsp;&nbsp; Common stock, par value $1.00 per share, Shares authorized – 160,000,000, Shares outstanding – 53,676,576 and 52,777,753 for 2022 and 2021, respectively | **53677** | 52778 |
| &nbsp;&nbsp;&nbsp; Additional paid-in capital | **266491** | 213637 |
| &nbsp;&nbsp;&nbsp; Retained earnings | **1741359** | 1600601 |
| &nbsp;&nbsp;&nbsp; Accumulated other comprehensive loss | **(451357)** | (270247) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total H.B. Fuller stockholders' equity | **1610170** | 1596769 |
| Non-controlling interest | **624** | 591 |
| **Total equity** | **1610794** | 1597360 |
| **Total liabilities, non-controlling interest and total equity** | $**4463629** | $4274530 |

---

------

---

| |
|:---|
| **CONSOLIDATED STATEMENTS of CASH FLOWS** |
| **H.B. Fuller Company and Subsidiaries** |
| **(In thousands)** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Fiscal Years** | **Fiscal Years** | **Fiscal Years** |
|  | **December 3,** | **November 27,** | **November 28,** |
|  | **2022** | **2021** | **2020** |
| **Cash flows from operating activities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income including non-controlling interest | $**180407** | $161475 | $123788 |
| Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation | **72593** | 72106 | 68226 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization | **74383** | 71068 | 70591 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred income taxes | **(15230)** | 16192 | (24730) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income from equity method investments, net of dividends received | **(9)** | 2776 | 375 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on sale of assets | **(1195)** | 648 | 86 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Share-based compensation | **24368** | 22366 | 16914 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pension and other postretirement benefit plan contributions | **(3009)** | (3840) | (5479) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pension and other postretirement benefit plan income | **(24021)** | (28662) | (14763) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mark to market adjustment related to contingent consideration liabilities | **-** | 2300 | 800 |
| Change in assets and liabilities, net of effects of acquisitions: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Trade receivables, net | **(24753)** | (124849) | (14842) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventories | **(55772)** | (135351) | 15708 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other assets | **46499** | (79097) | 38412 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Trade payables | **(22629)** | 176337 | 23130 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued compensation | **1135** | 27741 | 2588 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other accrued expenses | **6303** | 1186 | 16361 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income taxes payable | **(12873)** | (4137) | 5511 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other liabilities | **4104** | (73508) | 24566 |
| Other | **6213** | 108566 | (15683) |
| **Net cash provided by operating activities** | **256514** | 213317 | 331559 |
| **Cash flows from investing activities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchased property, plant and equipment | **(129964)** | (96089) | (87288) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchased businesses, net of cash acquired | **(250807)** | (5445) | (9500) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchased business assets | **-** |  | (5623) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from sale of property, plant and equipment | **1556** | 2896 | 1506 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash received from government grant | **3928** | 5800 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash outflow related to government grant | **-** | (1822) | (8555) |
| **Net cash used in investing activities** | **(375287)** | (94660) | (109460) |
| **Cash flows from financing activities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from issuance of long-term debt | **335000** |  | 300000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Repayment of long-term debt | **(159500)** | (156500) | (518000) |
| Payment of debt issue costs | **(600)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net proceeds from notes payable | **3455** | 9346 | 4128 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividends paid | **(39207)** | (34859) | (33461) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contingent consideration payment | **(5000)** | (1700) | (767) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Proceeds from stock options exercised | **30122** | 32325 | 12321 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Repurchases of common stock | **(3950)** | (2682) | (3432) |
| **Net cash provided by (used in) financing activities** | **160320** | (154070) | (239211) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of exchange rate changes on cash and cash equivalents | **(23423)** | (3335) | 5455 |
| **Net change in cash and cash equivalents** | **18124** | (38748) | (11657) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash and cash equivalents at beginning of year | **61786** | 100534 | 112191 |
| **Cash and cash equivalents at end of year** | $**79910** | $61786 | $100534 |

---